Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

447 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.
Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M. Langer I, et al. Among authors: Hess T. Ann Surg. 2007 Mar;245(3):452-61. doi: 10.1097/01.sla.0000245472.47748.ec. Ann Surg. 2007. PMID: 17435553 Free PMC article. Clinical Trial.
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial.
Weber WP, Tausch C, Hayoz S, Fehr MK, Ribi K, Hawle H, Lupatsch JE, Matter-Walstra K, Chiesa F, Dedes KJ, Berclaz G, Lelièvre L, Hess T, Güth U, Pioch V, Sarlos D, Leo C, Canonica C, Gabriel N, Zeindler J, Cassoly E, Andrieu C, Soysal SD, Ruhstaller T, Fehr PM, Knauer M; Swiss Group for Clinical Cancer Research (SAKK). Weber WP, et al. Among authors: Hess T. Ann Surg Oncol. 2018 Sep;25(9):2632-2640. doi: 10.1245/s10434-018-6556-9. Epub 2018 Jun 8. Ann Surg Oncol. 2018. PMID: 29948418 Clinical Trial.
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study.
Langer I, Guller U, Berclaz G, Koechli OR, Moch H, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M; Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer. Langer I, et al. Among authors: Hess T. Breast Cancer Res Treat. 2009 Jan;113(1):129-36. doi: 10.1007/s10549-008-9911-x. Epub 2008 Feb 23. Breast Cancer Res Treat. 2009. PMID: 18297394 Clinical Trial.
Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I, Guller U, Koechli OR, Berclaz G, Singer G, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M; Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer. Langer I, et al. Among authors: Hess T. Ann Surg Oncol. 2007 Jun;14(6):1896-903. doi: 10.1245/s10434-006-9193-7. Epub 2007 Mar 14. Ann Surg Oncol. 2007. PMID: 17356955 Clinical Trial.
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I, Guller U, Worni M, Berclaz G, Singer G, Schaer G, Fehr MK, Hess T, Viehl C, Bronz L, Schnarwyler B, Wight E, Infanger E, Burger D, Koechli OR, Zuber M; Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer. Langer I, et al. Among authors: Hess T. Ann Surg Oncol. 2014 Feb;21(2):401-7. doi: 10.1245/s10434-013-3315-9. Epub 2013 Oct 22. Ann Surg Oncol. 2014. PMID: 24145993 Clinical Trial.
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
Zappa F, Droege C, Betticher D, von Moos R, Bubendorf L, Ochsenbein A, Gautschi O, Oppliger Leibundgut E, Froesch P, Stahel R, Hess T, Rauch D, Schmid P, Mayer M, Crowe S, Brauchli P, Ribi K, Pless M; Swiss Group for Clinical Cancer Research (SAKK). Zappa F, et al. Among authors: Hess T. Lung Cancer. 2012 Dec;78(3):239-44. doi: 10.1016/j.lungcan.2012.08.017. Epub 2012 Sep 23. Lung Cancer. 2012. PMID: 23009726 Clinical Trial.
447 results
Jump to page
Feedback